All stock reportsPANACEABIO evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- Financial data quality flags require resolution.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-25T14:01:07.176647+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 6397700000.0
- net_income
- -53700000.0
- operating_cash_flow
- 173400000.0
- free_cash_flow
- -367500000.0
- total_assets
- 12621700000.0
- total_liabilities
- 4332900000.0
- total_equity
- 8348400000.0
- cash
- 643700000.0
- total_debt
- 236600000.0
- revenue_growth
- 0.14430592570069223
- earnings_growth
- -0.3584229390681004
- net_margin
- -0.00839364146490145
- roe
- -0.0064323702745436254
- debt_to_equity
- 0.02834075990608979
- cash_conversion
- -3.2290502793296088
- free_cash_flow_margin
- -0.057442518405051816
- trailing_pe
- Not supplied
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
Research only
1 opportunity assessments; compare evidence and conditions below.
Price Dislocation
Research only. Direction: LONG.
Flags large price dislocations for research without asserting unsupported fundamental quality
- No active, unexpired validation authority for this exact strategy and horizon.
- A source-backed entry, invalidation, exit and cost plan is not supplied.
- Eligible expression
- None selected
- Expression comparison
- No eligible instrument selected.
- Invalidation
- Continued price deterioration or adverse fundamental evidence
- Entry rule
- Not supplied
- Entry range (INR)
- Not supplied
- Exit / review rule
- Not supplied
- Planned exit
- Not supplied
- Plan valid until
- Not supplied
- Promotion reference
- Not supplied
- No reader capital or loss budget supplied
Decision provenance and limitations
- Decision ID
- decision-7e134809f65ef46111dd28c7a4d95d91f581d186e7cc9dd6a59e422067cb5a25
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 00d002a637b5510c090cfd8aa0dd442c317b27897bc35162fa1646d86d34d586
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 37b69010deeca7acebc6f7b7369f7c50d79524aa472cf390617140c70ff4e825
- daily-price: b9999d7b706e004715d2b4d3ebc25d877456775abd91f2a2640a386ac3871b4b
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 359.05.
- The trailing 5-session price return was -4.19%.
- The trailing 20-session price return was -6.09%.
- The trailing 60-session price return was -31.93%.
- The trailing 250-session price return was -11.27%.
- Average cached traded value over twenty sessions was INR 34,295,452.
- The closing price was -40.92% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-25T14:01:07.176647+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.14430592570069223.
- The cached financial metric net margin is -0.00839364146490145.
- The cached financial metric roe is -0.0064323702745436254.
- The cached financial metric debt to equity is 0.02834075990608979.
- The cached financial metric cash conversion is -3.2290502793296088.
- The cached financial metric free cash flow margin is -0.057442518405051816.
- Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.